# Claritin Reditabs

NDC: 11523-4329
Generic name: Loratadine
Labeler / Manufacturer: Bayer Healthcare LLC.
Product type: HUMAN OTC DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, ORALLY DISINTEGRATING
Routes: ORAL
Marketing started: 20021127

FDA application: NDA020704

## Active ingredients

- LORATADINE: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"11523-4329"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=11523-4329
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b681ea25-d00b-4c8a-8054-cc6f983ce337